Sarilumab

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Sarilumab and local guidelines before prescribing.

Biologic (anti-IL-6)

Mechanism

IL-6 receptor antagonist.

Uses

Rheumatoid arthritis, polymyalgia rheumatica.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Infections, neutropenia, raised LFT, GI perforation.

Interactions

Live vaccines contraindicated.

Contraindications and cautions

Active infection

Monitoring

FBC, LFT

Pregnancy and breastfeeding

Avoid

Renal and hepatic impairment

Caution in hepatic impairment

Overdose and reversal

Supportive

Special advice

Monitor FBC, LFT and lipids.

More from the textbook: uses, cautions and other points
Where it is discussed in the book